Chris Carter

In a report published Tuesday, Credit Suisse analyst Chris Carter reiterated an Outperform rating on WellCare Health Plans (NYSE: WCG), and raised the price target from $72.00 to $80.00. In the report, Credit Suisse noted, “We have revisited our WCG model following 3Q14 results. We have lowered our...

In a report published Thursday, Credit Suisse analyst Chris Carter upgraded the rating on WellCare Health Plans (NYSE: WCG) from Neutral to Outperform, but lowered the price target from $77.00 to $70.00. In the report, Credit Suisse noted, “We are upgrading shares of WCG to Outperform (from...

In a report published Thursday, Credit Suisse analyst Chris Carter initiated coverage on WellCare Health Plans (NYSE: WCG) with a Neutral rating, establishing a $77.00 price target. According to the report, while the analysts are positive on WCG and its strategy, they see NT risk around the...

In a report published Thursday, Credit Suisse analyst Chris Carter assumed coverage on Molina Healthcare (NYSE: MOH) with a Neutral rating, raising its price target to $42.00 from $37.00 According to the report, MOH is a multistate MCO focused on government end markets. The analysts fully expect...

In a report published Thursday, Credit Suisse analyst Chris Carter assumes coverage on Centene (NYSE: CNC) at Outperform, raising its price target to $72.00 from $70.00. According to the report, CNC is a leading multistate MCO focused on gov't end markets. We fully expect CNC to capture its fair...

In a report published Thursday, Credit Suisse analyst Chris Carter upgraded Aetna (NYSE: AET) from Neutral to Outperform, raising its price target to $83.00 from $69.00. According to the report, as an upside is seen to 2014 guidance from a continuation of muted cost trends and potential for...